Phase 2 randomized, flexible crossover, double-blinded, placebo-controlled trial of the farnesyltransferase inhibitor tipifarnib in children and young adults with neurofibromatosis type 1 and progressive plexiform neurofibromas

Imatinib mesylate for plexiform neurofibromas in patients with neurofibromatosis type 1: a phase 2 trial

(2012) Kent A Robertson et al.   LANCET ONCOLOGY

Chronic inhibition of mammalian target of rapamycin by rapamycin modulates cognitive and non-cognitive components of behavior throughout lifespan in mice

(2012) J. Halloran et al.   NEUROSCIENCE

Phase I trial and pharmacokinetic study of sorafenib in children with neurofibromatosis type I and plexiform neurofibromas

(2012) AeRang Kim et al.   PEDIATRIC BLOOD & CANCER

18-fluorodeoxyglucose-positron emission tomography (FDG-PET) evaluation of nodular lesions in patients with neurofibromatosis type 1 and plexiform neurofibromas (PN) or malignant peripheral nerve sheath tumors (MPNST)

(2012) Holly Meany et al.   PEDIATRIC BLOOD & CANCER

Adult hippocampal neurogenesis and related neurotrophic factors

(2011) Eu-Gene Lee et al.   BMB Reports

Resection of Plexiform Neurofibromas in Children With Neurofibromatosis Type 1

(2011) Federico Canavese et al.   JOURNAL OF PEDIATRIC ORTHOPAEDICS

Pediatric Plexiform Neurofibromas: Impact on Morbidity and Mortality in Neurofibromatosis Type 1

(2011) Carlos E. Prada et al.   JOURNAL OF PEDIATRICS

Phase I trial of pegylated interferon- -2b in young patients with plexiform neurofibromas

(2011) R. I. Jakacki et al.   NEUROLOGY

Characteristics of children enrolled in treatment trials for NF1-related plexiform neurofibromas

(2009) A. Kim et al.   NEUROLOGY

Immunosuppression Using the Mammalian Target of Rapamycin (mTOR) Inhibitor Everolimus: Pilot Study Shows Significant Cognitive and Affective Improvement

(2009) U.E. Lang et al.   TRANSPLANTATION PROCEEDINGS